This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Care ETFs: Elixir for Your Portfolio

With a 4.3% increase during February, the cost of medical care in the U.S. continues to increase at nearly double the 2.4% pace of overall prices. So, it's no surprise that exchange-traded funds are being launched to invest in the companies benefiting from this pricing power.

On March 12, XShares Advisors introduced one composite and eight new sub-industry-specific health care funds. These were added to the five HealthShares ETFs that have been in the XShares product portfolio since Jan. 23.

With the addition of these 14 health and biotech related ETFs, there are now 37 funds covering this sector. No other specific sector has as many ETFs.

Let's say you are reading a scientific journal about breakthroughs with promising new cancer drugs, and you decide to invest in a biotech company that specializes in cancer drugs. Instead of betting the house on a single company, you can now buy the HealthShares Cancer ETF (HHK). This fund is comprised of 64.9% pharmaceutical stocks and 35.1% biotechnology stocks. By making one investment in 22 companies actively seeking novel cancer treatments, the odds of holding the one stock that hits it big are increased.

Of course, the opposite can also true. Biotechnology and pharmaceutical stocks tend to be highly volatile, as potential new drugs succeed or fail at each stage of their clinical trials. So, if a proposed drug disappoints in trials or an existing drug is pulled from the market due to unacceptable side effects, expect to participate in the loss.

If your other investments are causing anxiety, depression and loss of sleep, or you are just plain absent-minded, the HealthShares Neuroscience ETF (HHN) holds the companies that want to bring help.

New XShares Advisors Funds
Fund Ticker Inception
HealthShares Autoimmune-Inflammation ETF HHA 3/12/2007
HealthShares Cancer ETF HHK 3/12/2007
HealthShares Cardiology ETF HRD 3/12/2007
HealthShares Composite ETF HHQ 3/12/2007
HealthShares GI/Gender Health ETF HHU 3/12/2007
HealthShares Metabolic-Endocrine Disorders ETF HHM 3/12/2007
HealthShares Neuroscience ETF HHN 3/12/2007
HealthShares Ophthamology ETF HHZ 3/12/2007
HealthShares Respitory/Pulmonary ETF HHR 3/12/2007
HealthShares Cardiology Devices ETF HHE 1/23/2007
HealthShares Diagnostic ETF HHD 1/23/2007
HealthShares Emerging Cancer ETF HHJ 1/23/2007
HealthShares Enabling Technology ETF HHV 1/23/2007
HealthShares Patient Care Services ETF HHB 1/23/2007

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.03 -2.90%
FB $116.73 7.20%
GOOG $691.02 -2.10%
TSLA $247.54 -1.60%
YHOO $36.59 -0.97%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs